Orgenesisâ CSO Sara Ferber to Present to the International Research Training Group Hosted by Technische Universität Dresden and the King’s College London

GERMANTOWN, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS), a developer of advanced cell therapies, manufacturer and service provider, today announced that Orgenesis’ Chief Scientific Officer, Sara Ferber Ph.D. will present the Company’s novel and proprietary autologous….


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.